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Deletion of l- and j-Opioid Receptors in Mice
Changes Epidermal Hypertrophy, Density of
Peripheral Nerve Endings, and Itch Behavior
Mei Bigliardi-Qi1,2, Claire Gaveriaux-Ruff3, Katrin Pfaltz4, Pierre Bady5, Tommy Baumann1, Theo Rufli4,
Brigitte L. Kieffer3 and Paul L. Bigliardi1,4
The m- (MOR) and k- (KOR) opioid receptors have been implicated in the regulation of homeostasis of non-
neuronal cells, such as keratinocytes, and sensations like pain and chronic pruritus. Therefore, we have studied
the phenotype of skin after deletion of MOR and KOR. In addition, we applied a dry skin model in these
knockout mice and compared the different mice before and after induction of the dermatitis in terms of
epidermal thickness, epidermal peripheral nerve ending distribution, dermal inflammatory infiltrate (mast cells,
CD4 positive lymphocytes), and scratching behavior. MOR knockout mice reveal as phenotype a significantly
thinner epidermis and a higher density of epidermal fiber staining by protein gene product 9.5 than the wild-
type counterparts. Epidermal hypertrophy, induced by the dry skin dermatitis, was significantly less developed
in MOR knockout than in wild-type mice. Neither mast cells nor CD4 Th-lymphocytes are involved in the
changes of epidermal nerve endings and epidermal homeostasis. Finally, behavior experiments revealed that
MOR and KOR knockout mice scratch less after induction of dry skin dermatitis than wild-type mice. These
results indicate that MOR and KOR are important in skin homeostasis, epidermal nerve fiber regulation, and
pathophysiology of itching.
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INTRODUCTION
Opioid receptors are involved in skin differentiation (Bigliar-
di-Qi, 2006; no. 812) and have been suggested to play
important role in itching (Metze, 1999; no. 292). We have
previously demonstrated that human epidermal keratinocytes
express the m-opiate receptor (MOR) at both the mRNA and
protein levels (Bigliardi et al., 1998). MOR and b-endorphin
were observed at peripheral nerve endings in skin (Stander
et al., 2002; Bigliardi and Bigliardi-Qi, 2004). In addition, the
expression of epidermal MOR was significantly decreased in
chronic pruritic skin diseases such as prurigo (Bigliardi and
Bigliardi-Qi, 2004) and atopic dermatitis (Bigliardi-Qi et al.,
2005). The density and quality of epidermal nerve endings,
stained by protein gene product (PGP) 9.5, were significantly
changed in chronic atopic dermatitis. The epidermal nerve
endings in the hypertrophic epidermis of chronic dermatitis
were thin and stretched. The density of PGP 9.5 staining per
unit of volume of epidermis was decreased. Altogether, these
results suggest that the opiate receptor system in epidermis is
functionally active and that the MOR system and its ligands
are involved in the pathogenesis of chronic pruritic skin
diseases, such as atopic dermatitis and prurigo. In addition,
there are several publications indicating that k-opioid
receptor (KOR) agonist can be used to treat different types
of pruritus (Togashi et al., 2002; Wakasa et al., 2004;
Wikstrom et al., 2005) and that KOR antagonists induce
itching (Kamei and Nagase, 2001).
Endogenous opioids are suspected of participating in the
acute and chronic itching process. Therapeutic options are
limited in chronic pruritus, as antihistamines are poorly
effective against chronic itching. The opioid antagonists
nalmefene (Ko and Naughton, 2000) and naloxone (Thomas
et al., 1993) not only reduce itching in patients who have
received spinal opiate injections of morphine but have also
been used to treat different forms of chronic pruritus (Bergasa
et al., 1995; Metze et al., 1999). Methylnaltrexone is a novel
quaternary derivative of naltrexone, which does not cross the
blood–brain barrier and which acts as a selective peripheral
opioid receptor antagonist. Intravenous or oral methylnal-
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trexone significantly decreases opioid-induced itching with-
out affecting analgesia (Foss, 2001; Friedman and Dello
Buono, 2001). Therefore, the antipruritic effect of naloxone is
due to the effects in the peripheral nervous system as well as
the central nervous system.
Previous studies have suggested that the peripheral opioid
receptor system is affected in chronic itching but not in acute
forms of itching (Bigliardi-Qi et al., 2005; Biro et al., 2005).
To support this hypothesis, we used a chronic itch model
with induction of dry skin dermatitis (Miyamoto et al., 2002)
on MOR and KOR knockout mice.
RESULTS
MOR and KOR mRNA expression in murine skin and murine
brain
Using MOR- and KOR-specific reverse transcriptase-PCR on
wild-type mouse skin, we found the PCR fragments with the
expected size at 352 bp for MOR and at 756 bp for KOR
(Figure 1). As expected, MOR knockout mice did not give any
PCR products with the MOR primers and KOR knockout mice
did not give any PCR products with the KOR primers (Figure
1c and g), although glyceraldehyde-3-phosphate dehydro-
genase amplification was normal.
Reduced epidermal hypertrophy in MOR and KOR knockout
mice after induction of chronic dermatitis
As expected, the induction of the dry skin dermatitis resulted
in an epidermal hypertrophy in male and female mice.
However, the epidermal hypertrophy was much more
pronounced in the treated wild-type mice (Figure 2a and c)
compared to the knockout mice (Figure 2b and d). This
means that the induction of chronic dermatitis is dramatically
reduced in MOR knockout mice and that knockout of the
MOR gene influences the induction of chronic dermatitis
especially in epidermis. The epidermis of the untreated MOR
knockout mice is reduced from 2–3 to 1–2 cell layers in male
and female mice (Figure 2f) and appears to be thinner
compared to the untreated epidermis in wild-type mice
(Figure 2e). The epidermal thickness in KOR knockout mice
was similarly reduced compared to the wild-type mice
(pictures not shown).
The epidermal thickness of MOR knockout and wild-type
mice with and without chronic dermatitis was measured in
triplicate for each animal using digital imaging analysis of
hematoxylin- and eosin-stained skin biopsy sections. The
variance of the measurements was stabilized using logarith-
mic transformation. The statistical analysis (Table S1) and the
box plot representation (Figure 3) confirmed the above-
mentioned morphological observations. The epidermis of
untreated male (average value (av) 16.6mm) and female (av
20.5 mm) MOR knockout mice was significantly thinner than
the epidermis of male (av 19.9 mm) and female (av 22.5 mm)
wild-type mice (Po0.002 analysis of variance (ANOVA); t-
test, maleo0.001; female¼0.005). This means that the MOR
knockout mice have a phenotype of an atrophic epidermis.
However, there was no significant difference between the
epidermal thickness of male and female wild-type and KOR
knockout mice (av male¼ 19.1 mm, female¼22 mm;
P¼0.116 ANOVA; t-test male P¼0.17; female P¼0.29).
In humans and animals, chronic dermatitis results in a
hypertrophic epidermis or a lichenification of the skin.
Therefore, it was not surprising to observe a marked
epidermal hypertrophy in wild-type mice (av male¼53.1 mm,
av female¼60.2 mm; Po0.001 ANOVA) after induction of
the dry skin dermatitis (treated). However, the epidermis of
MOR (av male¼ 36.4 mm, av female¼45.2 mm; P¼0.004
ANOVA; t-test male/femaleo0.001) and KOR (av mal-
e¼36.8 mm, av female¼51 mm; Po0.002 ANOVA; t-test
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Figure 1. PCR gels with the expected PCR product of 352 bp for mouse MOR
and 756 bp for mouse KOR. Lanes a/e¼ negative control, lane b¼mouse
brain (MOR), lane c¼ skin of wild-type mouse (MOR), lane d¼ skin of MOR
knockout mouse, lane f¼mouse brain (KOR), lane g¼ skin of wild-type
mouse (KOR), lane h¼ skin of KOR knockout mouse.
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Figure 2. Reduced epidermal hypertrophy in MOR knockout mice compared
to wild-type mice. Microscopic images of hematoxylin–eosin staining from
the paraffin-embedded sections of mouse rostral back skin after 5 days
treatment with AEW (acetone/diethylether/water). (a) Wild-type male, (b)
MOR knockout male, (c) wild-type female, (d) MOR knockout female after
induction of dry skin dermatitis, (e) untreated wild-type female, and
(f) untreated MOR knockout female; bar¼ 0.1 mm.
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maleo0.001, female¼0.005) knockout mice was signifi-
cantly thinner after induction of dry skin dermatitis than in
treated wild-type mice. This indicates that the lack of a
functional MOR and KOR partly prevents the development of
a hypertrophic epidermis. There was no significant difference
in epidermal thickness between male and female wild-type
mice (P¼0.074 ANOVA), MOR (P¼ 0.128 ANOVA) and
KOR (P¼ 0.07 ANOVA) knockout mice. Therefore, there is
no gender difference.
Increased epidermal expression of PGP 9.5 in MOR and KOR
knockout mice compared to wild-type mice
PGP 9.5 is a specific marker for peripheral nerve endings and
is commonly used to stain nerve endings in skin (Dalsgaard
et al., 1989). The amount of PGP 9.5 staining in epidermis in
MOR and KOR knockout mice and wild-type mice with or
without induction of dry skin dermatitis (treatment) was
quantified using confocal microscopy. The data were
stabilized using logarithmic transformation and then sub-
jected to statistic analysis (Table S2). The results were
visualized using a box plot representation (Figure 4). Contrary
to the epidermal thickness results, there is a striking gender
difference between male and female mice. Female mice have
a significantly higher density of epidermal PGP 9.5-positive
nerve fibers compared to the male mice (P¼ 0.001 ANOVA).
The average value for PGP 9.5 staining is 11.2 for male and
18.8 for untreated female wild-type mice. The untreated
MOR knockout mice (male av¼18.1, female av¼29.9) have
significantly more epidermal nerve fibers per given epidermal
volume than wild-type mice (P¼0.027 ANOVA; t-test
male¼ 0.005, femaleo0.001). KOR knockout mice (male
av¼ 15.9, female av¼ 20.3) showed the same trend, but
were marginally significant in ANOVA (P¼ 0.063 ANOVA;
t-test male¼0.003, female¼0.28). These observations in-
dicate that opioid receptors, especially the MOR, play an
important role in epidermal nerve density, as measured by
PGP 9.5. Therefore, MOR knockouts have a phenotype of
increased PGP 9.5-positive epidermal nerve endings. Never-
theless, the induction of dry skin dermatitis did not
significantly change the density of the epidermal nerve fibers
in male and female wild-type animals (P¼ 0.226 ANOVA). In
addition, there was no difference of PGP 9.5 staining before
and after treatment of male and female MOR (P¼0.664
ANOVA) and KOR (P¼0.164 ANOVA) knockout mice.
However, there was overall a significant reduction of
epidermal nerve fibers in female mice (MOR/KOR knockout
and wild type) after induction of dry skin dermatitis
(P¼0.005 ANOVA). Therefore, gender is an important factor
in the peripheral nerve distribution after induction of dry skin
dermatitis.
Figure 5 illustrates the relationship between epidermal
PGP 9.5 staining and the epidermal thickness. This relation-
ship is relatively weak. However, it seems that the PGP 9.5
values decrease with the increase of epidermal thickness and
that there is an important separation between the mice before
and after induction of dry skin dermatitis.
Expression of substance P in epidermis of treated MOR
knockout and wild-type mice
The substance P staining was semiquantified using digital
analysis of confocal microscopy images. The variance of the
triplicate data was stabilized by square transformation before
performing the statistical analysis (Table S3). Figure 6 shows
the box plot representation of this data. Firstly, there is a
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Figure 3. Boxplot representation of epidermal hypertrophy. Pictures were
taken from hematoxylin–eosin-stained paraffin sections from each animal and
the epidermal thickness of each biopsy was measured at three different
locations. The data of MOR and KOR knockout mice were compared to the
wild-type mice after logarithmic transformation. Number of animals: wild-
type untreated male (n¼9)/female (n¼ 10), wild-type treated male (n¼ 14)/
female (n¼9), MOR knockout untreated male (n¼ 7)/female (n¼ 7), MOR
knockout treated male (n¼8)/female (n¼ 8), KOR knockout untreated male
(n¼7)/female (n¼ 7), KOR knockout treated male (n¼6)/female (n¼ 6).
Panels compare the gender (a/b¼male against c/d¼ female) with (b/d) treated
and (a/c) untreated condition.
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Figure 4. Boxplot representation of epidermal PGP 9.5 staining. Numbers of
animals as in Figure 3. Panels compare the gender (a/b¼male against
c/d¼ female) with (b/d) treated and (a/c) untreated condition.
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significant increase of substance P-positive epidermal nerve
fibers (Po0.001 ANOVA) in untreated female animals
(av¼ 3.1) compared to untreated male mice (av¼ 0.33), as
also seen with the PGP 9.5 staining. The staining of epidermal
substance P in untreated male MOR knockout mice (av¼ 2.6)
increased significantly (P¼ 0.001 ANOVA; t-test 0.007)
compared to male wild-type mice (av¼0.33). The same
relationship was observed with PGP 9.5. The epidermal
substance P staining increased somewhat in untreated female
MOR knockout mice (av¼ 3.78) compared to untreated
female wild-type mice (av¼ 3.1; t-test 0.22). Induction of dry
skin dermatitis did not change the density of substance P
significantly (P¼ 0.116 ANOVA) in male and female wild-
type (male av¼0.94; female av¼ 2.77) and MOR knockout
mice (male av¼1.52; female av¼ 1.16). However, in the
MOR knockout, especially in the female mice, the epidermal
staining of substance P was reduced significantly (P¼0.013)
after treatment. Figure 7 illustrates the relationship between
substance P and PGP 9.5. There is some association between
the increase of PGP 9.5 staining and the epidermal substance
P staining. However, only around 1% of the epidermal nerve
fibers, stained by PGP 9.5, were also positively stained for
substance P.
Expression of mast cells and CD4 positive lymphocytes in
dermis of wild-type and MOR knockout mice
To evaluate the role of the inflammatory infiltrate in
epidermal hypertrophy in this chronic dermatitis model, we
evaluated the numbers of mast cells and CD4 positive
lymphocytes in the dermis. CD4 is present on a subset of
T-lymphocytes (‘‘helper/inducer’’ T cells) and is also expressed
at a lower level on monocytes, tissue macrophages, and
granulocytes. The antigen is involved in binding to major
histocompatibility complex class II molecules. The variances
of the measurements of dermal CD4 were stabilized by
square transformation. The quantification and statistical
analysis (Table S4) of the dermal infiltrate of CD4 positive
T-lymphocytes shows a significant difference only between
the mice with and without dry skin dermatitis (P¼0.019
ANOVA). As expected, the mice with dry skin dermatitis have
more infiltrate with CD4 positive lymphocytes (Figure 8). All
other tests could not reveal any significant difference. There is
no difference between male and female mice and the
knockout of the MOR did not change the inflammation
pattern in dermis (male: av untreated wild type¼7.8, av
treated wild type¼21.2, av untreated MOR¼4.9, av treated
MOR¼21.6; female: av untreated wild type¼3.7, av treated
wild type¼44.3, av untreated MOR¼6.7, av treated
MOR¼22.8 CD4 positive cells/mm2 in dermis).
Mast cells release the mediators of immediate hypersensi-
tivity, such as histamine, leukotriens, prostaglandins, and
platelet-activating factor. These factors have significant
effects on the inflammatory response and immediate and
late-phase allergic reactions. The mast cells were stained by
Giemsa stain and the total number of mast cells in 10
high power fields was counted for the statistical analysis
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Figure 5. Representation of the relationship between epidermal thickness
and epidermal PGP 9.5 staining. (a) Values grouped by type; (b) values
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and each point shows its standard deviation (both with logarithmic
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Figure 7. Representation of the relationship between epidermal staining of
substance P and PGP 9.5. (a) Values grouped by type; (b) values grouped by
treatment. The points correspond to the means by individual and each point is
associated with standard deviations; substance P¼ square transformation,
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(Table S5). The values are stabilized by logarithmic transfor-
mation. Figure 9 shows the findings in a box plot presenta-
tion. There are more mast cells in female mice compared to
male mice (P¼ 0.032 ANOVA). The t-test shows a significant
difference of dermal mast cell infiltration between female
wild-type and MOR knockout mice, but not in male mice
(t-test: wild type/MOR male treated and untreated P40.2;
wild type/MOR female untreated Po0.05, treated P¼0.05).
However, the ANOVA analysis cannot reveal a significant
difference (P¼0.086 in all animals) between wild-type and
knockout animals. There is no significant (P¼ 0.8 ANOVA;
t-test P40.2) increase of mast cells in dermis after induction
of dry skin dermatitis (male: av untreated wild type¼218.6,
av treated wild type¼244.1, av untreated MOR¼185, av
treated MOR¼211.5; female: av untreated wild
type¼ 334.7, av treated wild type¼402.9, av untreated
MOR¼185.2, av treated MOR¼ 287 Giemsa-positive cells/
mm2 in dermis).
In conclusion, these data suggest that mast cells do not
play a role in the pathogenesis of this dry skin dermatitis
model, because there is no direct and significant correlation
between treatment of animals and a weak correlation
between MOR knockout and wild-type mice. On the other
hand, the infiltrate of CD4 positive Th-lymphocytes is
significantly higher in mice after treatment. However, there
is no direct correlation between CD4 infiltrate and MOR
knockout and epidermal hypertrophy.
Scratching behavior of MOR and KOR knockout mice after
induction of dry skin dermatitis
The scratching behavior of the mice was measured as the
bouts of scratching per minute awake (bs/minute). Male and
female treated MOR knockout mice were compared to the
corresponding wild-type mice. The scratching behavior
counts reveal large variations. We observed that some
animals slept during the observation period of at least 1 hour
and that this also depended on the time of day. However, the
different animals (knockout, wild-type, male or female) were
not grouped during the observation periods, so group
differences simply owing to time of day were avoided. The
scratching behavior was taped by a digital video camera and
the bouts of scratching of each animal counted. The time
awake was additionally measured and the data finally
normalized to bouts of scratching per minute awake. All
the counts show a clear trend that MOR (male¼0.22;
female¼0.47) and KOR knockout mice (male¼0.38;
female¼0.69) scratch less than wild-type mice (male¼0.51;
female¼1.27 bouts of scratch/minute). The t-test revealed a
significant difference between male and female wild-type
and MOR knockout mice (Po0.05) but not between wild-
type and KOR knockout mice (male P¼ 0.27; female
P¼0.09). The ANOVA analysis was not so significant,
probably because there are no sufficient data available. A
classical linear model based on the co-variables sex (male/
female) and type (MOR/KOR knockout, wild-type) was used
for ANOVA analysis. Before statistical analysis, the values
were stabilized by logarithmic transformation. Figure 10
shows the box plot representation of the analysis of the bouts
of scratch per minute awake and (Table S6) the data of this
ANOVA analysis. The MOR and KOR knockout mice have a
tendency to scratch less than the wild-type mice after
induction of chronic dermatitis also in the ANOVA analysis.
The difference is significant in KOR knockout mice
(P¼0.010), but not in MOR knockout mice (P¼0.727).
Surprisingly, there is a highly significantly increased
(P¼0.007 ANOVA) scratching behavior in all female
animals compared to the male animals after induction of
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Figure 8. Boxplot representation of CD4-positive T-lymphocytes in dermis.
Formalin-fixed tissue from rostral back before and after induction of dry skin
dermatitis in wild-type and MOR knockout mice (seven mice in each case).
Panels compare the gender (a/b¼male against c/d¼ female) with (b/d) treated
and (a/c) untreated condition.
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Figure 9. Boxplot representation of counts of Giemsa-stain-positive mast
cells in dermis. Formalin-fixed tissue from rostral back before and after
induction of dry skin dermatitis in wild-type (untreated: male (n¼ 9), female
(n¼11); treated: male (n¼ 14), female (n¼9) and MOR knockout (untreated:
male (n¼ 8), female (n¼ 7); treated: male (n¼ 8), female (n¼ 8)) mice. Panels
compare the gender (a/b¼male against c/d¼ female) with (b/d) treated and
(a/c) untreated condition.
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dry skin dermatitis. This difference has also been observed in
the t-test in wild-type animals, but not in knockout mice
(Po0.05 wild-type; P¼ 0.14 MOR knockout and P¼0.18
KOR knockout).
DISCUSSION
In this study, we have shown that the lack of functional MOR
or KOR has an impact on epidermal homeostasis, distribu-
tion, and density of epidermal nerve endings and itching
behavior. The MOR, KOR, and also the d-opioid receptor
(Bigliardi-Qi et al., 2006) knockout mice have a hypotrophic
epidermis as phenotype and these mice also have a thinner
epidermis compared to wild-type littermates after induction
of dry skin dermatitis. In addition, the morphology of
epidermal nerve endings changes after knockout especially
of the MOR. The epidermal nerve endings are thicker and
more abundant and therefore the staining per volume of the
thinner epidermis is increased. In parallel, the staining for
substance P is increased in epidermis of male MOR knockout
animals. Moreover, the thicker nerve endings in knockout
animals are associated by less scratching behavior compared
to wild-type mice. The inflammatory infiltrate of mast cells or
CD4 positive T-lymphocytes does not correlate with these
alterations in skin of MOR knockout mice, suggesting that
inflammatory cells are not responsible for the above-
mentioned alterations.
The MOR, and to a lesser extent the KOR knockout mice
have a phenotype of a thinner epidermis compared to wild-
type mice. This important observation suggests that MOR and
to a lesser extent KOR are involved in the proliferation and
differentiation of keratinocytes. The epidermal hypertrophy in
chronic dry skin dermatitis might be a result of a mechanical
trauma, owing to the repetitive scratching of the treated area.
However, additional factors must exist other than mechanical
trauma for the epidermal hypertrophy, as it is hard for the
mice reaching the back of their neck. Epidermal homeostasis
could be directly affected by opioid receptors or by the
changed density of epidermal nerve fibers. Opioid receptors
can influence differentiation and proliferation of keratino-
cytes. We discussed this in a previous publication (Bigliardi-
Qi et al., 2006). Other authors observed that opioid ligands
regulate proliferation and DNA synthesis of basal keratino-
cytes (Zagon et al., 2000) and proliferation of human hair
follicle melanocytes (Kauser et al., 2004). This would argue
for a direct effect of the opioid system on skin homeostasis.
However, it is also well known that the change of epidermal
nerve endings can be influenced by neurotrophic factors.
Such trophic factors can increase the neuronal sensitivity
(Shu and Mendell, 2001) and initiate nerve fiber sprouting
and might therefore change the number of PGP 9.5-positive
nerve endings. In addition, it is known that neurotrophic
factors influence the proliferation of keratinocytes (Wilkinson
et al., 1994) and denervation of the skin slows keratinocytes
mitosis (Hsieh and Lin, 1999). However, there are not only
differences of epidermal hypertrophy in untreated animals
but also in the animals after induction of dry skin dermatitis.
The wild-type mice have a 2.6 times (males: 2.66; females:
2.68) thicker epidermis after induction of dry skin dermatitis
and the MOR (males: 2.18; females: 2.2) and KOR (males:
1.92; females: 2.32) knockout mice only about 2.2 times
thicker epidermis. Therefore, both wild-type and knockout
mice develop epidermal hypertrophy after induction of dry
skin dermatitis. However, the knockout mice have fewer
tendencies to epidermal hypertrophy owing to lack of opioid
receptor.
In this study, we observed that MOR and KOR knockout
mice scratch less. These results agree with other studies, such
as Miyamoto et al. (2002). In his dry skin dermatitis animal
model, the opioid receptor antagonists naloxone and
naltrexone significantly suppressed itching. Several other
studies have shown that the activation of MOR in mice
induces scratching behavior (Tohda et al., 1997; Kuraishi
et al., 2000). Nevertheless, we observed both reduction of
hypertrophy and decreased scratching behavior in knockout
mice. We cannot exclude that one caused the other, that is,
the changes in skin homeostasis caused the changes in
scratching or vice versa.
Obviously, itching in this dry skin dermatitis model is not
due to inflammation or mast cell activation, based on our
study and Miyamoto’s observations. Our results showed that
the amount of infiltrating mast cell staining was not different
in knockout and wild-type mice and did not change after
induction of dry skin dermatitis. The itching due to chronic
dry skin dermatitis was significantly increased in both mast
cell-deficient mice and normal littermates and the number of
scratching bouts was similar in mast cell-deficient mice and
normal ones (Miyamoto et al., 2002). However, pruritus was
increased in normal littermates compared to mast cell-
deficient mice if an acute dermatitis was induced by the
detergent sodium lauryl sulfate. These data suggest that the
triggers for chronic pruritus in the dry skin dermatitis model
and for the acute pruritus induced by a detergent are not the
same.
Similarly, the infiltrate of CD4 positive T-helper lympho-
cytes did not correspond to the differences in epidermal
hypertrophy and scratching behavior in male and female and
wild-type and knockout mice. There was only an increase of
CD4 lymphocytes in treated animals, as a sign of a slight
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Figure 10. Boxplot representation of scratching behavior
(log-transformation). The scratching behavior of the treated animals was
observed by video taping over 1 hour and the bouts of scratching were
counted. The number of scratching bouts was divided by the number of
minutes the mouse was awake during the time of the observation. Number of
animals: wild-type mice (male (n¼ 14), female (n¼ 9)), MOR (male (n¼ 8),
female (n¼8)) and KOR knockout mice (male (n¼7), female (n¼ 7));
(a) male, (b) female mice.
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inflammatory reaction with the dry skin dermatitis. The
inflammation with CD4 lymphocytes is not responsible for
the observed differences between wild-type and knockout
mice. These data correspond to previous publications using
the same MOR and KOR knockout mouse models. The
transgenic mice revealed immune parameters similar to their
wild-type counterparts for immune cell distribution, natural
killer activity, and basic serum immunoglobulin levels in the
absence of any treatment (Gaveriaux-Ruff et al., 1998, 2003).
The number of CD4 positive cells in the spleen of MOR
knockout mice was similar to the wild-type mice. However,
MOR knockout mice had an increased inflammation and
mortality in an experimental model of colitis (Philippe et al.,
2003). The inflammatory infiltrate is acute and severe in the
colitis model, in contrast to the slight and slowly increasing
inflammation in the dry skin model.
The density of free nerve endings in the epidermis is higher
in treated KOR and especially in MOR knockout compared
to wild-type mice. Pain sensing is enhanced, as found in
previous experiments using opioid receptor knockout mice
(Gaveriaux-Ruff and Kieffer, 2002). When pain sensation
is enhanced, the itch sensation is inhibited (Schmelz, 2005).
Pruritus is a well-known and hard to control side effect
of treatment with opioids for pain relief (Friedman and
Dello Buono, 2001). On the other hand, opioid receptor
antagonists, such as naltrexone and naloxone, have been
used to treat different forms of chronic pruritus (Terra and
Tsunoda, 1998; Metze et al., 1999; Zylicz et al., 2005).
There exist several double-blind placebo-controlled studies
proving the effect of naltrexone and naloxone in hepato-
genic pruritus (Bergasa et al., 1995; Wolfhagen et al., 1997;
Terg et al., 2002). In addition, plasma from patients with
the pruritus associated with chronic cholestasis induced
opioid receptor-mediated scratching in monkeys (Bergasa
et al., 1993) and the treatment of this pruritus in humans
with naltrexone precipitated an opioid withdrawal-like
reaction (Jones and Dekker, 2000). These observations
suggest a crucial role of the opioid receptor system and
its ligands, such as b-endorphin, in chronic cholestatic
pruritus. However, systemically applied naltrexone reduced
itching not only in hepatogenic pruritus but also in different
pruritic skin diseases, such as atopic dermatitis, xerosis cutis,
cutaneous lymphoma, and prurigo nodularis (Metze et al.,
1999).
Two important signs of chronic atopic dermatitis are
epidermal hypertrophy and an altered sensitivity. Does the
morphology and density of the epidermal nerve fibers
correlate with the itch sensation? Although the mechanism
of itching is still unknown, there are several morphologic
observations of the distribution of nerve fibers in pruritic skin.
Some authors describe a higher density of dermal nerve fibers
in patients with atopic dermatitis, but they do not mention the
density of epidermal nerve endings (Urashima and Mihara,
1998). Others observed reduced cutaneous neurite densities
in psoriasis, another classical pruritic dermatological condi-
tion (Pergolizzi et al., 1998). In chronic pruritic diseases, such
as atopic dermatitis, lichen simplex chronicus, and prurigo
simplex, we observed a significant downregulation of the
epidermal MOR expression and a changed morphology of the
epidermal nerve fibers (Bigliardi-Qi et al., 2005). In normal
skin, the epidermal nerve endings are rather thick and coil up
to the granular layer in the epidermis. However, in
hypertrophic epidermis associated with chronic atopic
dermatitis, the epidermal nerve endings are thin and run
straight through the epidermis (Bigliardi-Qi et al., 2005). The
epidermal nerve fibers seem to be stretched as the epidermis
is thickened. We made very similar observations in wild-type
and MOR knockout mice after induction of chronic dry skin
dermatitis. The treated wild-type mice have epidermal
hypertrophy, scratch more, and have stretched, thin epider-
mal nerve endings. On the other hand, the treated MOR
knockout mice have significantly less epidermal hypertrophy,
scratch less, and have thicker PGP 9.5-positive nerve
endings. In this case, the clinical observations from patients
with chronic atopic dermatitis correspond directly to the
experimental data obtained from transgenic mice. To our
surprise, the behavior of KOR knockout mice and MOR
knockout mice was similar. The KOR knockout mice
scratched less and had the same tendency as the MOR
knockout mice to have a thinner epidermis. This is somehow
contradictory to the clinical data using KOR agonists to treat
pruritus (Togashi et al., 2002; Wakasa et al., 2004; Wikstrom
et al., 2005). But it is known that the agonistic and
antagonistic effects of opioid ligands depend crucially on
the right concentration and the regulation of the receptor in
the target cell.
Female mice have a significantly higher density of
epidermal PGP 9.5-positive nerve fibers compared to the
male mice as phenotype. In addition, the female mice
generally scratched significantly more than the male in our
dry skin model. This gender difference in opioid pharmacol-
ogy or opioid receptor knockout animal models has also been
reported by other research groups and has been suggested to
be due to opioid gonadal hormone (Kepler et al., 1989; Islam
et al., 1993), estrogenous cycles (Berkley, 1997; Robinson
et al., 1998), and genetic background (Mogil et al., 2000).
Sexual dimorphism of response to opioid receptor system has
also been reported in humans, for example, opioid analgesia
was more marked in women than in men (Craft, 2003). The
density of epidermal nerve fibers is lower in men than in
woman (Goransson et al., 2004). The reason for this
difference is not known, but there are indications that
estrogen regulates neurotrophic factors such as the brain-
derived neurotrophic factor (Solum and Handa, 2002). In
addition, estrogen increases sensory nociceptor neuritogen-
esis (Blacklock et al., 2005). Interestingly, gender difference
in this mouse model plays an important role in the difference
of scratching behavior. However, giving the complexity of
the gender difference, the mechanism behind is not clear.
Many questions still remain to be answered but this study
clearly shows that the interaction between peripheral nerve
system and skin plays an important role in the pathogenesis of
chronic dry skin dermatitis. Especially, MOR and KOR
systems are key players in this interaction by affecting skin
homeostasis, skin innervation, and probably also itch
sensation.
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MATERIALS AND METHODS
Reverse transcriptase-PCR
For isolation of RNA, the cells were lysed directly on the culture dish
and mouse skin tissues were homogenized in lysis buffer. The
complementary DNA was synthesized from 1mg of total RNA using
random hexanucleotide primer (Promega Co, Madison, WI). The
PCR was performed with 40 cycles (Borner et al., 2004) using mouse
MOR primer pairs (352 bp): forward 50-CAAAATGAAGACTGCCAC
CAA-30 (357 bp) and reverse 50-TGGACCCCTGCCTGTATTTTGT-30
(709 bp); mouse KOR primer pairs (756 bp): forward 50-GTCTA
CTTGATGAATTCTTGG-30 (537 bp) and reverse 50-GGAAGCAG
GATCCTGAACTG-30 (1,293 bp); glyceraldehyde-3-phosphate
dehydrogenase primer pairs: forward 50-TGGCAGGTTTCTC
CAGGCGGC-30 and reverse 50-CCCACGGCAAGTTCAACGGCA-30
(605 bp).
Chronic itching model inducing dry skin dermatitis on MOR
knockout mice
The local ethical committee has approved the experiment. MOR and
KOR gene knockout mice have been described previously (Kieffer
and Gaveriaux-Ruff, 2002). Animals were fully backcrossed on
C57Bl6 background and their wild-type littermates used for controls.
These mice were about 10 months old and had free access to food
and water with 12 hours day and night cycle. Mice were housed
individually for 10 days before experiment. All the mice were shaved
over the rostral part of the back 3 days before the start of the
experiment.
The chronic dry skin dermatitis model was performed according
to Miyamoto et al. (2002). Briefly, mice were anesthetized with
isoflurane (Baxter). Cotton soaked with a mixture of acetone and
diethylether (1:1) was laid upon the shaved area for 15 seconds.
Immediately after acetone and diethylether treatment, cotton
soaked with distilled water was laid upon the same area for
30 seconds. The above treatment was performed twice daily (0900
and 1700 hours) for 5 days. The control mice were also shaved and
anesthetized.
After 5 days treatment, the scratching behavior was recorded for
1 hour using a digital video camera (JVC, Yokohama, Japan). For each
observation period, four mice were put individually into separate
Plexiglas boxes. The mice were acclimatized to the experimental
environment for 60 minutes and then videotaped for at least
1 hour (60–75 minutes). The scratching by the hind paws in the neck
area was counted. The mice generally made several scratching
movements for about 1 second. One series of movements was
counted as one bout of scratching. Playback was used to count the
scratching movements. The number of scratching bouts was divided
by the minutes the mouse was awake during the time of the
observation.
The mice were then killed and skin specimens taken from the
rostral back of treated and untreated animals, fixed in 4%
formaldehyde or frozen in dry ice, and then stored at 701C for
future use. For measurement of epidermal thickness, the samples
were stained with hematoxylin and eosin and the thickness
measured at three different locations using a digital imaging analysis
program (PicEd Cora, Jomesa, Munich, Germany). The pictures were
taken using an inverted microscope (Nikon Diaphot 300, Tokyo,
Japan) with a digital CCD color camera (CF 20 DXC, Kappa
Messtechnik, Gleichen, Germany).
Staining of the mouse skin samples (PGP 9.5, substance P, CD4,
and mast cells)
For immunohistochemistry, the samples were deparaffinized in
xylol, dehydrated in ethanol (100, 96, 90, 80, 70, and 50%), distilled
H2O, and phosphate-buffered saline (pH 7.0–7.2). For PGP 9.5
(UltraClone 1:1,500) and substance P (Neuromics 1:200) staining,
the sections were incubated at 41C over night in Zamboni buffer. The
samples were boiled in 0.01 M sodium citrate solution in a
microwave oven for 10 minutes and cooled down to room
temperature and then blocked with 5% normal goat serum for
1 hour at room temperature. The primary antibodies were incubated
over night at 41C and corresponding secondary antibodies Cy2- or
Cy3-conjugated goat anti-rabbit IgG (Hþ L) (Jackson Immuno
Research Laboratories, West Grove, PA) were used.
Confocal microscopy was performed with a Zeiss Confocal Laser
Scanning Microscope LSM 510, inverted Axiovert 100M (Carl Zeiss
AG, Jena, Germany). It operates in the sequential acquisition mode
to exclude crosstalk between channels. The 488 (for Cy2) and 568
(for Cy3) excitation lines were used and the optics were a Zeiss Plan-
Neofluar  40 oil immersion objective with a numerical aperture of
1.3. Optical sections of 0.75 mm thickness were scanned through the
z-plane of the sample. Images were taken from at least three different
sections of each block (tested animal) and the staining was
quantified using the IMARIS statistic software package. Each series
was semiquantified using the same settings adjusted to the back-
ground with a negative control staining without primary antibody.
Thickness of the specimen was always taken as 6mm and
semiquantification was performed on z-stack (eight stacks in total).
The CD4 positive lymphocytes in the dermis were visualized
using rat anti-mouse CD4 mAb (BD Pharmingen, San Diego, CA)
and StreptAvidin system with horseradish peroxidase-labeled sec-
ondary antibody. The CD4 positive cells were counted from pictures
at  40 magnification taken in five different fields using an inverted
microscope (Nikon Diaphot 300, Tokyo, Japan) equipped with a
digital CCD color camera (CF 20 DXC, Kappa Messtechnik,
Gleichen, Germany).
Mast cells were visualized using Giemsa staining. Briefly, the
sections were deparaffinized at 601C for 45 minutes and hydrated in
xylol, ethanol (100, 96, and 70%), and distilled water. The
deparaffinized slides were stained in a May–Gru¨nwald solution
(Merck, Darmstadt, Germany) for 15 minutes and then were put into
Giemsa stain solution (Merck) for 65 minutes. The stained slides
were evaluated on a light microscope. Ten randomly chosen high-
power fields ( 40 magnification) were studied from each slide. The
total number of mast cells in 10 high-power fields was used for the
statistical analysis.
Statistical analysis
All the data obtained from digital imaging analysis and behavior
experiments had undergone statistical analysis using ANOVA, and a
linear mixed-effects model (Laird and Ware, 1982; Pinheiro and
Bates, 2000) was used. This type of model takes into consideration
the individual variability of each mouse. Each mouse was considered
as a random draw in the large population. Systematic tests of
interactions of the first order between the co-variables were
conducted for each model. The co-variables were sex (male/female),
genotype (wild type, MOR and KOR knockout mice), and treatment
(with or without induction of dry skin dermatitis). These effects of co-
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variables were compared to the reference mice, which corresponded
to the untreated male wild-type mice. Therefore, the intercept
mentioned in the tables corresponds to the reference mice (untreated
male wild-type mice). Logarithmic and square transformation was
used to stabilize the variance of the measurements. These
transformations are frequently used for modeling of biological
processes of growth or multiplication. All statistical analyses were
performed on R version 2.1.1 (http://www.r-project.org/) (Ihaka and
Gentleman, 1996) and the mixed linear model was computed with
the library nlme (Pinheiro and Bates, 2000). The data are presented
as tables and Box plot representations. Additionally, in all samples
the average was calculated and in addition the significance by
Student’s t-test (page 1/type 2) was supplied.
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